Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase 1/2 3Phase 2 2Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 149Lymphoma 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Lymphoma, Large B-Cell, Diffuse 46Leukemia 44Lymphoma, Follicular 39Lymphoma, Non-Hodgkin 35Multiple Myeloma 33Leukemia, Lymphocytic, Chronic, B-Cell 28Leukemia, Myeloid, Acute 25Burkitt Lymphoma 24Neuroblastoma 21Lymphoma, Large-Cell, Immunoblastic 16Hodgkin Disease 16Lymphoma, Mantle-Cell 14Neoplasms 13Triple Negative Breast Neoplasms 12Lymphoma, B-Cell, Marginal Zone 11Sarcoma 10Inflammatory Breast Neoplasms 10Rhabdomyosarcoma 8Recurrence 8Neoplasms, Plasma Cell 8Myelodysplastic Syndromes 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Graft vs Host Disease 8Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Leukemia, Biphenotypic, Acute 7Lung Neoplasms 6

Interventions

Ifosfamide 6Doxorubicin 6Radiotherapy 4Filgrastim 2Etoposide 2trofosfamide 1pegfilgrastim 1indolepropanol phosphate 1fludarabine 1anlotinib 1Watchful Waiting 1Tablets 1Rosuvastatin Calcium 1Radiotherapy, Conformal 1Observation 1Midazolam 1Idarubicin 1Digoxin 1Diathermy 1Dacarbazine 1Cyclophosphamide 1Combined Modality Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Synovial × Cyclophosphamide × Clear all
NCT07174427 2026-02-18

Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma

Takara Bio Inc.

Phase 3 Recruiting
5 enrolled
Sarcoma

Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡